Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Thai Sade, co-founder and CEO of BloomX, joined Cheddar News to discuss how the company helps farmers profit off of AI-based pollination technology.
The Manhattan District Attorney’s office has asked owners and landlords to commence eviction proceedings on unlicensed shops that have popped up all over the city following cannabis legalization across New York in 2021.
Over 400 food products are being recalled over possible listeria contamination.
HIV and AIDS have long had a disproportionate impact on the Black community. In recognition of that stark reality, the U.S. government marked February 7 as National Black HIV/AIDS Awareness Day.
New York dropped its vaccine requirement for city workers.
The Biden administration is set to boost the health standards of meals provided in public schools across the U.S.
The Food and Drug Administration still hasn't regulated the cannabis compound CBD — and the agency said it has no plans to.
World food prices fell in January for the 10th straight month, according to data.
An arctic blast is hitting the Northeast as millions are dealing with wind chills that could hit as low as 60 below zero.
Aerospace startup Atomos Space, which is developing a series of orbital transfer vehicles to help reposition satellites in space, recently closed on a $16 million financing round. CEO Vanessa Clark and COO William Kowalski joined Cheddar News to discuss the company's operations ahead of its launch.
